North America — Consolidated revenues
Geographic · Consolidated revenuesThermo Fisher Scientific North America — Consolidated revenues increased by 1.8% to $5.69B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $5.59B to $5.69B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the company's offerings in North America, while a decrease may signal competitive pressure, economic headwinds, or reduced regional customer spending.
Detailed definition
This metric represents the total gross sales generated by the company within the North American geographic region. It en...
Peer comparison
Comparable to regional revenue reporting by other global life sciences and diagnostics firms, which often break out performance by major geographic theaters to highlight localized growth drivers.
tmo_segment_north_america_consolidated_revenuesHistorical Data
| Q2 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $4.53B | $6.32B | $6.03B | $5.69B | $5.69B | $5.69B | $5.69B | $5.59B | $5.69B |
| QoQ Change | — | +39.6% | -4.6% | -5.7% | +0.0% | +0.0% | +0.0% | -1.8% | +1.8% |
| YoY Change | — | — | +33.2% | -10.0% | -5.7% | — | — | -1.8% | +1.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's north america — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported north america — consolidated revenues of $5.69B in Q3 2025.
- How has Thermo Fisher Scientific's north america — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's north america — consolidated revenues increased by 1.8% year-over-year, from $5.59B to $5.69B.
- What does north america — consolidated revenues mean?
- The total amount of money earned from sales made within the North American market.